Lippincott Williams & Wilkins

For prophylaxis against pneumocystis jiroveci pneumonia patients in both treatment arms received trimethoprim/ sulfamethoxazole unless contraindicated. Study exclusion criteria included diagnosis of Eosinophylic Granulomatosis with polyangiitis (Churg Strauss syndrome), active infection (including active or documented hepatitis B or C), severe ... ................
................